Raloxifene Hydrochloride
Product Images NDC 63629-8209

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 63629-8209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl636298209)

Label Image (Lbl636298209)
This appears to be a label of Raloxifene 60mg Tablet made by Amneal Pharmaceuticals Pvt. Ltd. The tablet is oval and white with the imprint AN057. It should be stored at room temperature between 20°C-25°C (68°F-77°F) and kept out of reach of children. The label also includes the NDC code and an expiration date field.*
FDA Label Image

Chemical Structure (Raloxifene HCl Tablets Usp 1)

FDA Label Image

Image 1 (Raloxifene HCl Tablets Usp 2)

Image 1 (Raloxifene HCl Tablets Usp 2)
The text provides data for the Total hip mean percentage change from baseline in placebo and Raloxifene HC subjects for 24 months from two different studies (NA and EU) as well as data for Raloxifene HC, placebo and CE subjects for 24-month from Study INT in hysterectomized women. The data is presented for the duration of 0, 6, 12, 16 and 24 months after randomization. The study INT used a conjugated estrogen 0.625 mg/day. The analysis used the intent to treat approach with the last observation carried forward.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.